NFKB1 and psoriasis: In the CD18 hypomorphic (CD18hypo) mouse model of psoriasis, treatment with the IκB kinase inhibitor acetyl-11-keto-β-boswellic acid (AKβBA) profoundly suppressed NF-κB signaling and subsequent cytokine production [155].